Neurovascular Devices Market share to reach $2.3bn by 2024: Global Market Insights Inc. According to research report “Neurovascular Devices Market Size By Product (Embolic Coils, Carotid Stents, Intracranial Stents, Neurovascular Thrombectomy, Embolic Protection Devices, Flow Diverters, Intrasaccular Devices, Liquid Embolic Coils, Balloons, Stent Retrievers), By Process (Neurothrombectomy, Cerebral Angiography, Stenting, Coiling, Flow Disruption), By Therapeutic Application (Brain Aneurysm, Stenosis, Ischemic Strokes), By End Use (Hospitals, Clinics, Ambulatory Surgical Units), Industry Analysis Report, Regional Outlook (U.S., Canada, UK, Germany, France, Spain, Italy, Russia, Japan, China, India, Australia, Korea, Brazil, Mexico, Argentina, Saudi Arabia, UAE, South Africa), Growth Potential, Competitive Market Share & Forecast, 2016 – 2024”, by Global Market Insights, Inc., Neurovascular Devices Market is slated to surpass a revenue of USD 2.3 billion by 2024, growing with a CAGR of 4.1% over 2016-2024. Escalating prevalence of brain-related disorders coupled with the popularity of minimally invasive surgeries will spur neurovascular devices market. With the healthcare sector growing at a rapid pace across the globe, the demand for these medical devices has exponentially increased, thereby providing a positive impetus to global neurovascular devices market.
The demand for minimally invasive surgeries has perpetually increased worldwide, propelled by the reduced hospital stays, favorable medical insurance and reimbursement policies, and the convenience and accuracy of these surgical procedures. This in turn, will stimulate neurovascular industry over the coming years of 2016 to 2024. This market is highly consolidated and includes the participation of giants such as Stryker, Johnson & Johnson, Terumo, Medtronic, and Penumbra. Reportedly, Stryker has a lion’s share in global neurovascular devices market revenue, primarily owing to the clever business tactics undertaken by the company at regular intervals. The lack of skilled neuro-medical experts and the rising cost of neurovascular devices is likely to pose a restraint to global neurovascular devices industry growth. Key participants, however, are working toward effectively combating these restraints by means of strategic acquisitions and innovative product developments. Neurovascular devices are principally utilized in end-use sectors such as hospitals, ambulatory surgical units, and clinics. Hospitals are estimated to depict the highest growth rate between 2016-2024, having accounted for over 85% of the overall 1|Page
industry share in 2015. Neurovascular devices market from ambulatory surgical units is expected to grow significantly, especially across the U.S. and Germany, owing to the high prevalence of brain disorders pertaining to the rising obese population in the region. U.S. Neurovascular Devices Market Size, By Therapeutic application, 20122024 (USD Million)
Browse key industry insights spread across 210 pages with 243 market data tables & 7 figures & charts from the report Neurovascular Devices, in detail along with the table of contents: https://www.gminsights.com/industry-analysis/neurovascular-devices-market Speaking of the United States, the country accounted for more than 71.6% of global neurovascular devices market share in 2015 and is projected to grow remarkably over the coming years, essentially driven by the highly developed medical infrastructural facilities, a rapidly rising patient pool, increased healthcare expenditure, and technological innovations in neuroscience. The rise in healthcare spending is also observed to be a major growth driver for APAC neurovascular devices industry, especially across countries such as India, China, and Japan. In fact, Japan is slated to hold more than 47% of Asia Pacific neurovascular devices market by 2014. The rise in per capita income, low cost production facilities, and favorable healthcare insurance will further augment the regional growth. Rise in GDP may also be a key factor promoting the growth of neurovascular devices industry in developing economies such as Brazil. Latin America, with Brazil at the helm, will observe the highest growth of 5.5% over 2016-2024, driven by the rising prevalence of brain-related disorders and an increase in the number of geriatric patients. Leading companies are concentrating on neurovascular research 2|Page
& development activities and expanding their footprint in the untapped regions of emerging economies to sustain their position in global neurovascular devices market. Neurovascular devices comprise embolic protection devices, liquid embolic coils, embolic coils, stent retrievers, flow diverters, carotid stents, balloons, neurovascular thrombectomy, intracranial stents, and intrasaccular devices. Flow diverters and stent retrievers are anticipated to exhibit the highest growth rate over 2016-2024. Thrombectomy neurovascular devices market is expected to register a revenue of more than USD 300 million by 2024. Embolic coils dominated the product landscape of neurovascular devices industry by accounting for a share of more than 30% of the overall revenue in 2015. The increasing usage of these products in coiling and other neurovascular procedures will stimulate the industry growth. Speaking of which, neurovascular devices market from coiling procedures is slated to depict the maximum gain over 2016-2024, with a revenue estimation of more than USD 750 million by 2024. This growth can be attributed to the technological advancements embedded in these devices coupled with the rising number of personal and government funding for novel product development. Driven by favorable reimbursement plans, neurovascular devices market from stenting procedure is predicted to record the highest CAGR over 2016-2024. Rising adoption of carotid stents and balloon catheters by neurosurgeons for agile treatment procedure will further fuel the industry growth. Neurovascular devices find applications in stenosis, brain aneurysm, and ischemic strokes. The world is witnessing an exponential rise in the number of patients suffering from aneurysms and strokes. As per reliable sources, more than 4% of the population in America is suffering from aneurysms. Neurovascular devices market from ischemic strokes is estimated to observe the highest growth between 20162024. Brain aneurysm, having held a share of more than 70% of overall neurovascular devices industry in 2015, will depict a substantial growth rate over the coming years, due to increased penetration of aneurysms among the age group of 35 to 60, especially across emerging economies. Strategic mergers & acquisitions are key growth strategies adopted by neurovascular devices market players for expanding their presence across the globe. Such collaborations also help companies concentrate on clinical trials to enable the marketing of cost-effective procedures.
3|Page
Table of Contents of Neurovascular Devices Market:
Chapter 1 1.1
1.2
Methodology and Scope Methodology
1.1.1
Initial data exploration
1.1.2
Statistical modeling and forecast
1.1.3
Industry insights and validation
1.1.4
Definitions & assumptions
Data Sources 1.2.1
Primary
1.2.2
Secondary
Chapter 2 Executive Summary 2.1
Neurovascular devices industry 3600 synopsis, 2012 - 2024 2.1.1
Business trends
2.1.2
Application trends
2.1.3
Process trends
2.1.4
Regional trends
Chapter 3 Neurovascular devices Industry Insights 3.1
Industry segmentation
3.2
Industry size and forecast, 2012 - 2024
3.3
Industry impact forces 3.3.1
4|Page
Growth drivers
3.3.1.1 Increasing number of brain aneurysm and ischemic strokes 3.3.1.2 Rise in demand for surgical procedures with minimum invasion 3.3.1.3
Advancement in process
3.3.1.4 Government initiatives to modernize and expand healthcare infrastructure 3.3.2
Industry pitfalls & challenges 3.3.2.1
Need for designing more effective and low cost treatments
3.3.2.2 Companies are facing challenges in commercialization across the developing economies 3.4
Growth potential analysis
3.5
Competitive landscape, 2015 3.5.1
Strategy dashboard
3.6
Porter’s analysis
3.7
PESTEL analysis
About Global Market Insights:
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider; offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy and biotechnology.
5|Page
Contact Us:
Arun Hegde Corporate Sales, USA Global Market Insights, Inc. Phone: 1-302-846-7766 Toll Free: 1-888-689-0688 Email: sales@gminsights.com Website: https://www.gminsights.com/
6|Page